Smith Salley Wealth Management Has $10.69 Million Stock Position in Colgate-Palmolive Company $CL

Posted by Geri Gentry on Jun 22nd, 2026

Smith Salley Wealth Management grew its holdings in Colgate-Palmolive Company (NYSE:CL – Free Report) by 7.7% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 125,425 shares of the company’s stock after acquiring an additional 8,959 shares during the quarter. Smith Salley Wealth Management’s holdings in Colgate-Palmolive were worth $10,690,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of CL. Evolve Private Wealth LLC grew its position in shares of Colgate-Palmolive by 2.5% during the 1st quarter. Evolve Private Wealth LLC now owns 7,657 shares of the company’s stock worth $653,000 after purchasing an additional 189 shares in the last quarter. Triad Wealth Partners LLC bought a new position in shares of Colgate-Palmolive during the first quarter worth approximately $229,000. Quotient Wealth Partners LLC raised its position in shares of Colgate-Palmolive by 67.7% in the first quarter. Quotient Wealth Partners LLC now owns 5,298 shares of the company’s stock valued at $452,000 after buying an additional 2,138 shares in the last quarter. AEGON ASSET MANAGEMENT UK Plc raised its position in shares of Colgate-Palmolive by 45.6% in the first quarter. AEGON ASSET MANAGEMENT UK Plc now owns 948,572 shares of the company’s stock valued at $80,894,000 after buying an additional 297,268 shares in the last quarter. Finally, E. Ohman J or Asset Management AB boosted its stake in shares of Colgate-Palmolive by 5.6% in the first quarter. E. Ohman J or Asset Management AB now owns 491,735 shares of the company’s stock valued at $41,911,000 after buying an additional 26,206 shares during the period. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Performance

NYSE CL opened at $89.74 on Monday. The firm’s 50 day simple moving average is $87.40 and its 200 day simple moving average is $86.65. The firm has a market capitalization of $71.81 billion, a price-to-earnings ratio of 34.92, a P/E/G ratio of 4.72 and a beta of 0.33. The company has a current ratio of 1.02, a quick ratio of 0.67 and a debt-to-equity ratio of 16.33. Colgate-Palmolive Company has a 1 year low of $74.54 and a 1 year high of $99.33.

Colgate-Palmolive (NYSE:CL – Get Free Report) last announced its quarterly earnings data on Friday, May 1st. The company reported $0.97 EPS for the quarter, beating the consensus estimate of $0.94 by $0.03. Colgate-Palmolive had a net margin of 10.04% and a return on equity of 386.76%. The business had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.22 billion. During the same period in the previous year, the business earned $0.91 earnings per share. The company’s revenue was up 8.4% on a year-over-year basis. As a group, research analysts expect that Colgate-Palmolive Company will post 3.81 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Monday, July 20th will be paid a $0.53 dividend. The ex-dividend date is Monday, July 20th. This represents a $2.12 annualized dividend and a dividend yield of 2.4%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 82.49%.

Analysts Set New Price Targets

A number of brokerages recently issued reports on CL. UBS Group increased their price target on Colgate-Palmolive from $98.00 to $100.00 and gave the stock a “buy” rating in a research report on Monday, May 4th. Barclays lifted their price objective on Colgate-Palmolive from $79.00 to $80.00 and gave the company an “equal weight” rating in a report on Tuesday, May 5th. Piper Sandler cut their target price on Colgate-Palmolive from $96.00 to $92.00 and set an “overweight” rating for the company in a research report on Wednesday, April 8th. Royal Bank Of Canada reissued an “outperform” rating and set a $102.00 target price on shares of Colgate-Palmolive in a report on Monday, May 4th. Finally, Rothschild & Co Redburn set a $100.00 price target on Colgate-Palmolive and gave the stock a “buy” rating in a research report on Tuesday, April 21st. Twelve analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and a consensus price target of $95.88.

Read Our Latest Analysis on CL

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.